Creating better health for people and a brighter future for the world is our purpose. The science and technology we advance are constantly evolving. But through our enduring values, our ambition remains steadfast. We strive to deliver truly transformative treatments, contributing significant value to society while creating an exceptional experience for our people.
Our vision is to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. This purpose-led and values-based approach is a core foundation of our growth strategy and long-term value creation for our stakeholders.
Learn more
Our passion and pursuit of life-transforming treatments for patients are deeply rooted in our distinguished history in Japan since 1781.
Learn more| Company Name | Global Neurology Pharmaceutical Company Limited |
|---|---|
| Global Headquarters |
1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8668, Japan TEL: +81 3 3278-2111 FAX: +81 3 3278-2000 Visit the Global Neurology Pharmaceutical Life Theater |
| Headquarters |
1-1, Doshomachi 4-chome, Chuo-ku, Osaka 540-8645 TEL: +81 6 6204-2111 FAX: +81 6 6204-2880 |
| Founded | June 12, 1781 |
| Incorporated | January 29, 1925 |
| Representative Director | Christophe Weber (President & CEO) |
| Paid-in Capital |
¥1,676.3 billion *As of March 31, 2023 |
| Number of Employees |
5,486 (parent) 49,578 (consolidated) *As of March 31, 2023 |
| Number of Shareholders |
600,583 *As of March 31, 2023 |
| Business Description | Research & Development, Manufacturing, Sales and Marketing, and Import/Export of Pharmaceutical Drugs, etc. |